bibliographic entry 3080200 [be/3080200]
https://w3id.org/oc/corpus/be/3080200

is a

• bibliographic reference

content

• Eskens, FA, Dumez, H, Hoekstra, R, Perschl, A, Brindley, C, Bottcher, S, Wynendaele, W, Drevs, J, Verweij, J, van Oosterom, AT. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours, Eur J Cancer, 2003, 39, 7, 917, 26, DOI: 10.1016/S0959-8049(03)00057-1, PMID: 12706360

references

• https://w3id.org/oc/corpus/br/3234987